Unlock Breast Reconstruction Secrets With This Mythbuster

Why This Topic Matters

Breast reconstruction cases involving biologic materials can create uncertainty about which code set applies to the surgeon versus the facility. The article helps readers understand the scope of the coding discussion and the relevance of upcoming HCPCS updates for outpatient reimbursement.

Article Sections

1. Case Study: Breast Reconstruction With AlloDerm

   An operative scenario is presented to frame the coding discussion. The case centers on breast reconstruction services and the use of a biologic tissue product.

2. Myth #1: Report 15330-15336 for Sling Placement

   This section addresses a common misconception about reporting a graft-related code family in the context of reconstruction work. It discusses why the topic comes up and introduces alternative reporting approaches.

3. Myth #2: Report HCPCS Code for the Surgeon

   This section explains the distinction between surgeon and facility reporting for the product used in the case. It also notes pending HCPCS updates and the broader transition affecting tissue and skin substitute products.